# Molluscum Contagiosum

Molluscum contagiosum is usually a clinical diagnosis managed with observation or lesion-directed treatment, but genital disease, atypical morphology, bacterial superinfection, and extensive or refractory lesions require a different diagnostic and immunologic assessment.

**Clinical question:** How should physicians diagnose, treat, counsel, and escalate care for molluscum contagiosum across immunocompetent and immunocompromised patients?

Updated: 2026-09-15T23:37:50.430578+00:00

## What matters in practice
- Typical 2–5 mm pearly or skin-colored umbilicated papules are diagnosed clinically; use dermoscopy or biopsy when morphology, distribution, or host factors make the diagnosis uncertain. [5][6][12]
- For uncomplicated non-genital disease in an immunocompetent patient, observation is reasonable because lesions commonly resolve spontaneously within 6–18 months. [6][13]
- Treat when lesions are extensive, complicated by dermatitis or bacterial infection, cosmetically burdensome, genital in adults, or occurring with immunosuppression; select a lesion-directed approach based on site, burden, and tolerance. [10][12][19]
- Extensive, giant, confluent, verrucous, facial, or persistent molluscum should trigger assessment for immunosuppression, especially HIV; in HIV-associated extensive disease, immune restoration with ART is the primary intervention. [2][9][14]
- Do not exclude children from school, daycare, or swimming solely because of molluscum; cover lesions and discourage scratching and sharing towels, clothing, or sports equipment. [22]

## Confirm the diagnosis and identify patients who need escalation

The lesion pattern and host context determine whether clinical diagnosis is sufficient.

Diagnose molluscum clinically when discrete, firm, shiny, skin-colored or pink papules have a central umbilication, usually measuring approximately 2–5 mm. A hand lens or dermatoscope improves recognition of central yellow-white amorphous structures with peripheral crown vessels. In a child, truncal, limb, facial, axillary, or diaper-area lesions support nonsexual transmission; in adults, genital, inner-thigh, or lower-abdominal lesions should prompt assessment for sexual transmission. [5][6][19]

Use lesion scraping with microscopy or punch/shave biopsy when papules are atypical, solitary and large, ulcerated, plaque-like, rapidly changing, or diagnostically consequential. Histology shows endophytic epidermal hyperplasia with pear-shaped lobules and large intracytoplasmic molluscum bodies. Biopsy is particularly important when a lesion could instead represent a keratoacanthoma, basal cell carcinoma, squamous cell carcinoma, condyloma, or another papular tumor. [5][6][12]

Treat extensive, giant, coalescent, verrucous, unusually distributed, facial, or treatment-refractory lesions as an immunologic warning pattern rather than routine childhood molluscum. HIV-associated disease may be persistent, recurrent, disseminated, and concentrated on the head, neck, or genital region; severe or atypical disease can be a correlate of cellular immune deficiency. In an immunosuppressed patient with disseminated umbilicated papules, retain disseminated cryptococcosis, histoplasmosis, and bacillary angiomatosis in the differential and obtain tissue diagnosis when lesions are not convincingly typical. [2][14][24]
- Ask about atopic dermatitis, topical or systemic immunosuppressive therapy, transplant, chemotherapy, HIV risk or known HIV, lesion manipulation, contact sports, and shared towels, clothing, razors, or equipment. Atopic dermatitis is associated with higher lesion counts and molluscum dermatitis. [1][19][20][21]
- Examine for eczematous inflammation around lesions and for honey-colored crust, purulence, warmth, progressive tenderness, or spreading erythema that would redirect management toward bacterial superinfection. [10][12]
- In a sexually active adolescent or adult with genital lesions, evaluate for other sexually transmitted infections; new-onset adult molluscum in an appropriate epidemiologic context should also prompt HIV testing. [6][9]

*Clinical patterns that change the diagnostic next step. [2][5][6][12][14][24]*

| Presentation | Key discriminator | Next action |
| --- | --- | --- |
| Typical clustered small umbilicated papules in an immunocompetent child | Classic morphology and usual pediatric distribution | Clinical diagnosis; discuss observation versus treatment based on symptoms, burden, and family preference. [6][13] |
| Genital lesions in a sexually active adolescent or adult | Sexual transmission is plausible | Assess for other STIs; counsel to avoid sexual contact pending clinical evaluation and lesion management. [6][21] |
| Giant, confluent, verrucous, plaque-like, facial, or disseminated papules | Atypical morphology or distribution suggests impaired cellular immunity or an alternative diagnosis | Review immune status, test for HIV when indicated, and biopsy if diagnosis is uncertain. [2][4][14][24] |
| Crusted, tender, purulent, or cellulitic lesions | Secondary bacterial infection | Assess and treat bacterial infection; avoid traumatizing inflamed lesions until infection is addressed. [10][12] |
| Atypical umbilicated lesions in a markedly immunosuppressed patient | Deep fungal infection or other systemic disease can mimic molluscum | Obtain biopsy for histopathology rather than assuming molluscum. [24] |

## Choose observation or active clearance based on burden and consequences

The decision to treat is individualized; treatment is not mandatory for every immunocompetent patient.

Offer observation for uncomplicated, non-genital molluscum in immunocompetent patients when lesions are asymptomatic and the patient accepts a potentially prolonged course. Spontaneous clearance commonly occurs within 6–18 months; many children clear in 6–9 months, although longer persistence occurs. Observation avoids procedure-related pain, blistering, pigmentary change, and scarring risk from destructive therapy. [6][13]

Favor active treatment when lesions are extensive, repeatedly autoinoculated, associated with eczema or bacterial superinfection, cosmetically distressing, located in areas where friction causes symptoms, or genital in adults. The evidence base and practice patterns support lesion-directed approaches, but treatment selection should account for age, number and location of lesions, skin sensitivity, pain tolerance, and the ability to return for office care. [10][12][17][19]

Do not use topical imiquimod routinely in children: it has not demonstrated effectiveness in children and may cause adverse effects. Cantharidin is an office-applied blistering agent; avoid presenting it as a home therapy. Cryotherapy, curettage, potassium hydroxide, podophyllotoxin, and cantharidin have been associated with higher clearance in systematic reviews, but comparative evidence varies across interventions and populations. [7][8][10][17]
- Use curettage when rapid physical removal is desired and the patient can tolerate a procedure; balance immediate clearance against pain, bleeding, and procedure-related skin injury. Curettage is commonly selected for adult genital lesions in practice. [19]
- Use cryotherapy for selected accessible lesions when repeat office treatments and local inflammatory effects are acceptable; it was the most common treatment choice across several physician specialties in a U.S. survey. [19]
- Use office-applied cantharidin when a blistering approach is appropriate for lesion location and patient tolerance; counsel that application must be performed by a healthcare provider. [10]
- Reserve treatment of facial or periocular lesions for cases in which lesion burden, ocular involvement, cosmesis, or transmission risk justifies intervention; periocular lesions can be associated with follicular conjunctivitis. [24]

### Managing associated dermatitis and infection

Molluscum dermatitis and pruritus can drive scratching and autoinoculation, so identify and manage the eczematous component while considering lesion-directed therapy. Escalating erythema, purulence, warmth, tenderness, or crusting suggests bacterial secondary infection, which is the most common complication and is more consequential in immunocompromised patients. [10][12][19]

*Practical treatment selection by clinical scenario. [7][8][10][12][13][19]*

| Scenario | Reasonable approach | Key tradeoff or limitation |
| --- | --- | --- |
| Few asymptomatic lesions, immunocompetent patient | Observation with transmission-reduction counseling. [6][13] | Clearance may take 6–18 months. [6] |
| Multiple accessible lesions requiring clearance | Consider office cantharidin, cryotherapy, or curettage. [7][8][10][19] | Destructive approaches can be painful or provoke local inflammation; choice depends on site and tolerance. [10][19] |
| Child with uncomplicated disease | Avoid imiquimod; use observation or selected lesion-directed therapy. [10][13] | Imiquimod is not proven effective in children and may cause adverse effects. [10] |
| Extensive disease with atopic dermatitis | Address eczematous inflammation and consider active lesion treatment if spread, symptoms, or burden are substantial. [1][12][19] | Atopic dermatitis is associated with more lesions and molluscum dermatitis. [1][19] |
| Immunocompromised patient with extensive disease | Evaluate the immune deficit and prioritize immune restoration when applicable; consider dermatology input for local disease control. [10][14] | Traditional lesion therapies may respond poorly in HIV/AIDS or other immunosuppressing conditions. [10] |

## Approach extensive molluscum in HIV and other immunosuppression

Atypical disease should prompt immune assessment and exclusion of mimics.

For patients with HIV, extensive or unusually distributed molluscum is best managed by addressing the underlying immune deficit. ART is recommended as the primary treatment for extensive and/or unusually distributed HIV-associated molluscum; lesion improvement has been observed with immune recovery, although individual response is variable. [9][14]

Do not rely on conventional destructive therapy alone in advanced HIV or other major immunosuppression. Patients may have persistent, recurrent, fulminant, disseminated, large, hypertrophic, or coalescent lesions and often respond incompletely to traditional treatments. If lesions are atypical or systemic infection is plausible, biopsy before repeated destructive procedures. [10][14][24]

In an adult with new-onset molluscum and unknown HIV status, offer HIV testing when clinical setting and epidemiology indicate risk; formal WHO guidance specifically recommends testing adults with new-onset disease in high HIV-prevalence settings. In U.S. practice, extensive, facial, giant, refractory, or disseminated lesions should lower the threshold for HIV screening and medication review. [9][14]
- Review transplant status, chemotherapy, biologic therapy, systemic corticosteroids, and other immunosuppressive drugs when disease is extensive or refractory. [20][21]
- Obtain pathology in an immunocompromised patient when lesions are clinically indistinguishable from disseminated cryptococcosis, histoplasmosis, or bacillary angiomatosis. [24]
- For facial lesions in severely immunocompromised patients, intralesional interferon has been used in extreme cases, but severe adverse effects including flu-like symptoms, site tenderness, depression, and lethargy limit its desirability. [10]

*Immune-status branch for extensive or atypical disease. [2][9][10][14][24]*

| Finding | Interpretation | Action |
| --- | --- | --- |
| Persistent, disseminated, recurrent, or disfiguring molluscum in known HIV | Cutaneous manifestation of impaired cellular immunity | Ensure ART evaluation/initiation or optimization; use lesion-directed treatment selectively for local control. [2][14] |
| New extensive, giant, facial, or unusual molluscum in unknown HIV status | HIV or another immune deficit is possible | Perform HIV screening when clinically indicated and review immunosuppressive exposures. [9][20][21] |
| Atypical umbilicated papules with systemic illness or profound immunosuppression | Molluscum mimics include disseminated fungal infection and bacillary angiomatosis | Biopsy before assuming benign viral disease. [24] |

## Reduce autoinoculation and transmission without unnecessary exclusion

Counseling should address direct contact, fomites, scratching, and sexual transmission.

Advise patients to avoid picking, shaving through, or scratching lesions because disruption promotes autoinoculation and can create a portal for bacterial infection. Cover lesions that cannot be fully clothed, particularly during contact activities, and use individualized coverings for swimming or similar settings. [20][22]

Counsel against sharing towels, clothing, razors, sports equipment, toys, or other personal items that contact lesions. Direct skin contact, contaminated items, and autoinoculation all contribute to spread; athletes in close-contact settings and households should receive the same practical precautions. [11][20][21][22]

Do not recommend exclusion from school, daycare, or swimming for children solely due to molluscum. CDC advises that attendance is unnecessary to restrict; covering lesions reduces transmission and also limits scratching. [22]

For anogenital molluscum, advise abstaining from sexual contact until clinical evaluation, because direct skin contact can transmit infection and sexual transmission may coexist with other STIs. Evaluate sexually active adolescents and adults for other STI risks rather than assuming all genital lesions are nonsexual. [6][21]
- Use separate towels and wash clothing, towels, and sports gear after use; do not share unwashed personal items. [11][20][21]
- Cover lesions before contact sports, school activities, or swimming when feasible. [22]
- Reassess promptly for increasing pain, purulence, spreading erythema, or extensive new lesions, which suggest bacterial complication, autoinoculation, or an unrecognized immune problem. [10][12][20]

*Counseling by exposure setting. [11][20][21][22]*

| Setting | Recommended action | What not to do |
| --- | --- | --- |
| School or daycare | Allow attendance; cover lesions and limit scratching. [22] | Do not exclude solely because of molluscum. [22] |
| Swimming or pool activities | Cover lesions with a watertight bandage when possible and avoid sharing towels or equipment. [22] | Do not prohibit swimming solely because of lesions. [22] |
| Contact sports or locker rooms | Cover lesions and avoid sharing towels, clothing, and equipment. [11][20] | Do not leave lesions uncovered during close skin contact when coverable. [22] |
| Sexual contact | Avoid sexual contact pending evaluation and discuss STI assessment. [6][21] | Do not assume genital lesions require no additional sexual-health evaluation. [6] |

## References
1. Systematic Review of the Epidemiology and Risk Factors for Nonsexual Transmission of Warts and Molluscum in Children - Montyn Lücher - 2025 - Pediatric Dermatology - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/pde.16002?af=R
2. Molluscum contagiosum in patients with human immunodeficiency virus infection: A review of twenty-seven patients — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/0190962292702266
3. The epidemiology of molluscum contagiosum in children - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0190962205026502
4. Molluscum Contagiosum En Plaque – An Unusual... : Indian Dermatology Online Journal — journals.lww.com — https://journals.lww.com/idoj/fulltext/2024/15030/molluscum_contagiosum_en_plaque___an_unusual.22.aspx
5. Molluscum contagiosum - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/immunology-and-microbiology/molluscum-contagiosum
6. Molluscum contagiosum - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/neuroscience/molluscum-contagiosum
7. Treatments for Molluscum contagiosum: A systematic review — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111/ddg.70100
8. Comparative efficacy of treatments for molluscum contagiosum: A ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/ddg.15063
9. Evidence and recommendations on molluscum contagiosum - Guidelines on the Treatment of Skin and Oral HIV-Associated Conditions in Children and Adults - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK305396
10. Clinical Overview of Molluscum Contagiosum | Molluscum Contagiosum | CDC — www.cdc.gov — https://www.cdc.gov/molluscum-contagiosum/hcp/clinical-overview
11. Molluscum contagiosum: Overview — www.aad.org — https://www.aad.org/diseases/a-z/molluscum-contagiosum-overview
12. Molluscum contagiosum: an update and review of new perspectives in etiology, diagnosis, and treatment - PubMed — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pubmed/31239742
13. Molluscum contagiosum: Diagnosis and treatment — www.aad.org — https://www.aad.org/public/diseases/a-z/molluscum-contagiosum-treatment
14. [PDF] Guidelines on the treatment of skin and oral HIV-associated ... - IRIS — iris.who.int — https://iris.who.int/server/api/core/bitstreams/50196a71-51c6-4e05-ade2-36e013a450fe/content
15. [PDF] National Comprehensive HIV Care Guideline 2018 — www.afro.who.int — https://www.afro.who.int/sites/default/files/2019-04/National%20Comprehensive%20HIV%20Care%20%20Guideline%202018.pdf
16. [PDF] Manual on Paediatric HIV Care and Treatment for District Hospitals — iris.who.int — https://iris.who.int/server/api/core/bitstreams/bb24ec3c-7477-44e1-bb05-de7ab4ad60f4/content
17. Interventions for cutaneous molluscum contagiosum - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC6481355
18. Molluscum contagiosum effectively treated with a topical acidified ... — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7161892
19. Understanding U.S. Healthcare Providers’ Practices and Experiences with Molluscum Contagiosum - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC3796559
20. Molluscum Contagiosum - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK441898
21. Molluscum Contagiosum: Epidemiology, Considerations, Treatment ... — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10453394
22. Preventing Molluscum Contagiosum in Schools, Daycares, and Pools | Molluscum Contagiosum | CDC — www.cdc.gov — https://www.cdc.gov/molluscum-contagiosum/special-environments
23. Emerging infectious diseases of the skin: a review of clinical and histologic findings — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0046817723001478
24. Molluscum Contagiosum Virus - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/neuroscience/molluscum-contagiosum-virus

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.